Finally, we observed that in clinical samples, CPT1A expression is reduced in tumors compared to normal kidneys, and significantly that CPT1A activity is reduced in mitochondria harvested from tumor tissue compared to adjacent normal kidney tissue. This evidence concerns the gene CPT1A and neoplasm.